Similar Articles
471 Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis
472 Impact of heart failure on outcomes in patients with sepsis: A systematic review and meta-analysis
473 Acute respiratory distress syndrome and severe pneumonitis after atezolizumab plus bevacizumab for hepatocellular carcinoma treatment: A case report
474 Current and novel approaches in the pharmacological treatment of hepatocellular carcinoma
475 Different types of fruit intake and colorectal cancer risk: A meta-analysis of observational studies
476 Efficacy and safety of intravenous tranexamic acid in total shoulder arthroplasty: A meta-analysis
477 Radiomic advances in the transarterial chemoembolization related therapy for hepatocellular carcinoma
478 Surgical treatment for recurrent hepatocellular carcinoma: Current status and challenges
479 Ablative strategies for recurrent hepatocellular carcinoma
480 Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA